4.6 Article

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation

Lei Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Modeling clear cell renal cell carcinoma and therapeutic implications

Melissa M. Wolf et al.

ONCOGENE (2020)

Review Urology & Nephrology

Potential New Therapeutic Approaches for Renal Cell Carcinoma

David C. Yang et al.

SEMINARS IN NEPHROLOGY (2020)

Review Biochemistry & Molecular Biology

SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis

Yuanzhen Ma et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Article Biochemistry & Molecular Biology

MEXPRESS update 2019

Alexander Koch et al.

NUCLEIC ACIDS RESEARCH (2019)

Review Urology & Nephrology

Metabolomics and Metabolic Reprogramming in Kidney Cancer

Robert H. Weiss

SEMINARS IN NEPHROLOGY (2018)

Review Biochemistry & Molecular Biology

Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer

Rehman Ata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism

Weinan Du et al.

NATURE COMMUNICATIONS (2017)

Article Medicine, Research & Experimental

miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis

Shaojun Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Oncology

SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery

Neetu Saxena et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Article Oncology

SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery

Neetu Saxena et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Article Oncology

Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas

Vera Miranda-Goncalves et al.

CURRENT CANCER DRUG TARGETS (2016)

Review Biochemistry & Molecular Biology

PKM2, cancer metabolism, and the road ahead

Talya L. Dayton et al.

EMBO REPORTS (2016)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Review Oncology

Metabolic alterations in renal cell carcinoma

Francesco Massari et al.

CANCER TREATMENT REVIEWS (2015)

Article Biochemistry & Molecular Biology

Electron-Transfer Pathways in the Heme and Quinone-Binding Domain of Complex II (Succinate Dehydrogenase)

Robert F. Anderson et al.

BIOCHEMISTRY (2014)

Review Biochemistry & Molecular Biology

Tumor glycolysis as a target for cancer therapy: progress and prospects

Shanmugasundaram Ganapathy-Kanniappan et al.

MOLECULAR CANCER (2013)

Review Biochemistry & Molecular Biology

Cancer epigenetics reaches mainstream oncology

Manuel Rodriguez-Paredes et al.

NATURE MEDICINE (2011)

Article Urology & Nephrology

The genetic basis of kidney cancer: a metabolic disease

W. Marston Linehan et al.

NATURE REVIEWS UROLOGY (2010)

Review Biochemistry & Molecular Biology

Succinate dehydrogenase deficiency in human

JJ Brière et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2005)

Article Oncology

Lactate: Mirror and motor of tumor malignancy

S Walenta et al.

SEMINARS IN RADIATION ONCOLOGY (2004)